Hints and tips:
Related Special Reports
...Investor excitement about Zealand comes as pharma groups seek to follow Novo Nordisk and Eli Lilly into the lucrative obesity market....
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...Jeff Emmick, Eli Lilly’s senior vice-president of product development, said that while as many as 80mn US adults may suffer from obstructive sleep apnoea, about a quarter of whom face more serious symptoms...
...The addition of Amazon Pharmacy to Eli Lilly’s direct-to-consumer dispensing network is the first time Amazon has partnered with a big drug company since it launched its online pharmacy business in 2020....
...Dear reader, It isn’t often that a company pays good money to criticise customers for buying its product. But that is what Eli Lilly did this week....
...BSP previously produced Covid antibody treatment bamlanivimab for Eli Lilly....
...In the race to develop a small molecule pill, Eli Lilly’s phase 3 orforglipron was “a bit of a frontrunner”, Novo Nordisk’s Lange acknowledged, but he said it was not as effective as injectables....
...US drug regulators have delayed a decision on whether to approve Eli Lilly’s breakthrough Alzheimer’s drug, which was expected to be greenlit this month, the drugmaker said on Friday....
...Patients on the donanemab study had more advanced Alzheimer’s than patients on similar studies, Eli Lilly said....
...Eli Lilly’s share price fell as much as 2.4 per cent in early US trading before later recovering its losses....
...Demand for a new class of diabetes and obesity drugs will boost US drugmaker Eli Lilly’s sales by 20 per cent in 2024, pushing its revenues above $40bn, the company said on Tuesday....
...Amazon Pharmacy stands to generate “a lot of revenue” from drugs such as Eli Lilly’s Zepbound injection and Novo Nordisk’s Wegovy, which are both available to patients directly through the Amazon website...
...Eli Lilly has called for competition regulators to scrutinise an $11bn deal by its main competitor Novo Nordisk to snap up additional manufacturing capacity, as the rivalry between the drugmakers to dominate...
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...Mounjaro will become available “within weeks” in Great Britain for treatment of both diabetes and obesity, after the medicines regulator authorised US pharma company Eli Lilly on Thursday to sell the weight...
...Eli Lilly lowered its expectations for full-year earnings because of accounting charges related to recent acquisitions, despite beating expectations in the third quarter driven by growth in diabetes and...
...Indianapolis-based Eli Lilly, meanwhile, has become the world’s largest pharmaceutical company on the back of sales of its drug Mounjaro for diabetes and strong trial results for its use in weight loss....
...Regulators on both sides of the Atlantic have cleared Eli Lilly’s injectable diabetes medication for use as a weight loss treatment, creating the first direct rival to Wegovy, Novo Nordisk’s obesity drug...
...The US federal drug regulator has approved Eli Lilly’s injectable diabetes medication for weight loss, as demand for the blockbuster treatments continues to surge....
...This is a very small deal for a company as big as Eli Lilly. The drugs giant is riding high on diabetes drug Mounjaro, which has potential use as a weight-loss treatment....
...Eli Lilly, the world’s largest drugmaker, plans to bolster its portfolio of cancer drugs by buying Point Biopharma for $1.4bn, paying a premium of almost 90 per cent to Monday’s closing price....
...Eli Lilly has agreed to buy cancer biotech Point Biopharma for about $1.4bn, paying a premium of almost 90 per cent to Monday’s closing price amid a severe cash crunch in the biotech industry....
...Hassabis stated the goal days after announcing Isomorphic Lab’s first two pharmaceutical partnerships with Eli Lilly and Novartis, which came to a combined value of up to $3bn, in deals set to transform...
...They include the popular new diabetes and weight-loss drugs Ozempic and Wegovy, made by Novo Nordisk, and Mounjaro and Zepbound made by Eli Lilly....
International Edition